Dr. Barry Dworkin

Diabetes drug, Pioglitazone seems to inhibit the growth of certain types of prostate cancer. Further evaluation is needed due to the small study size but the science is sound.

Medical Mythbusting Commentary for May 27, 2025

Source:
Diabetes Drug Stops Prostate Cancer From Coming Back

Reference:
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer

Related posts:

  1. Early stage study shows virus can destroy prostate cancer cells
  2. Early animal studies of prostate cancer vaccine are encouraging
  3. Prostate cancer surgery results no different from not doing the surgery: study
  4. Focused-beam-ultrasound trial will investigate efficacy to treat early stage prostate cancer